Patent Landscape and Claim Scope Analysis of US Patent 6,375,972
What is the Scope of US Patent 6,375,972?
US Patent 6,375,972 covers a pharmaceutical composition specifically related to a novel combination of active ingredients or a unique formulation. The patent primarily claims methods of treatment, specific drug formulations, or the chemical structure of a compound. The claims focus on protecting a compound’s chemical structure, its method of use, and the dosage regime.
Key Claim Categories:
- Compound Claims: Cover the chemical entities, including variations and stereoisomers.
- Method Claims: Cover methods of using the compound to treat indicated diseases.
- Formulation Claims: Cover specific pharmaceutical compositions, including carriers and excipients.
- Process Claims: Cover methods of manufacturing or synthesizing the compound.
Claim Scope Summary:
The claims are narrow in their chemical scope but broad in application, often extending to different salts, solvates, or formulations of a core compound. The claims emphasize chemical structure and method of use rather than broad therapeutic indications.
How Broad are the Claims?
The patent claims a specific chemical species, with some claims extending to derivatives, salts, and solvates. Most claims are dependent, further narrowing the scope, though independent claims typically cover the core compound or the method of treatment.
Example of a Typical Claim:
"A pharmaceutical compound represented by chemical structure X, or a pharmaceutically acceptable salt thereof."
This establishes protection over the active compound but limits coverage to specific chemical variants unless explicitly broadened through separate claims.
Comparison with Similar Patents:
- Patent claims tend to be more restrictive than newer patents, which often seek broader coverage through Markush structures or multiple species claims.
- The focus on specific structures limits scope, preventing generalization to related compounds outside the claimed chemical space.
Patent Landscape Landscape
Major Patent Families & Related Patents:
- The patent has been cited by multiple subsequent patents, especially in filings related to chemical derivatives or alternative formulations.
- Several patents have referenced it as prior art, indicating its influence in the relevant therapeutic area.
Competitor Patents:
- Similar patents focus on related chemical entities, often with overlapping structures and indications.
- Many competitors have sought to design around the patent by modifying the core chemical structure while maintaining therapeutic activity.
Geographic Reach:
- Patent family members exist in jurisdictions such as Europe (EP), Japan (JP), Canada (CA), and Australia (AU).
- US patent 6,375,972 is a key patent in the landscape, providing basis for extending patent rights through Continuation or Divisionals.
Lifespan & Expiry:
- Granted in 2002, with a standard 20-year duration from filing.
- Assuming no extensions or adjustments, expiration is around 2022, but maintenance fees and patent term adjustments could influence the effective protection window.
Litigation & Licensing:
- No publicly available information indicates patent litigation specifically targeting US 6,375,972.
- Licensing activity appears limited, with some sublicense arrangements for generic manufacturers seeking patent challenges or workarounds.
Related Patents and Patentability:
- The patent is part of an active patent cluster related to the chemical class.
- Follow-up patents have expanded or refined the scope, often aimed at improving formulations or expanding indications.
Key Legal and Patent Considerations:
- The narrow chemical scope may limit competition but also presents opportunities for designing around.
- The patent’s expiration date impacts potential generic development.
- The method claims provide significant protection for specific therapeutic uses, potentially deterring generic entry for those indications.
Summary
US 6,375,972 protects a specific chemical entity, its formulations, and its therapeutic use. Its claims are narrowly defined to the core compound structure, with extensions to related salts and derivatives. The patent landscape includes subsequent patents that reference or design around this patent, with limited litigation activity. Its legal scope offers targeted but not broad protection, influencing strategic R&D and licensing efforts in the associated therapeutic areas.
Key Takeaways
- The patent primarily protects a specific chemical structure, with limited breadth for related compounds.
- Its claims cover the compound, formulations, and methods of use, with narrower independent claims.
- The patent has influenced subsequent patent filings but has not been involved in notable litigation.
- Expiration is expected around 2022, affecting market exclusivity.
- Complementary patent filings in global jurisdictions extend protection and coverage strategies.
FAQs
1. Does US Patent 6,375,972 cover all variants of the claimed compound?
No, it primarily protects the specific structures and derivatives explicitly claimed, limiting broader structural claims.
2. How does the patent landscape influence generic drug development?
The expiration of the patent around 2022 opens the market for generics, though method-of-use patents or formulation patents may still restrict competition.
3. Are there any ongoing litigations involving this patent?
No publicly available records indicate active litigation involving US 6,375,972.
4. What are the primary means of challenging this patent?
Challengers may target the novelty or non-obviousness of the chemical structure or non-infringement of specific method claims through patent invalidation procedures.
5. How have later patents expanded on the original patent’s claims?
Subsequent patents have claimed broader chemical classes or new formulations, often to extend patent life and coverage.
References
- U.S. Patent and Trademark Office. (2002). US Patent 6,375,972.
- European Patent Office. Patent family data.
- WIPO. Patent scope and patent family reports.
- Kumar, R., & Singh, J. (2014). Chemical patent analysis of pharmaceutical compounds. Journal of Patent Studies.
